
If you or someone you care for is living with cognitive decline, it can be difficult to make sense of Alzheimer’s treatments, medications, and the many lifestyle recommendations you may encounter.
This page is designed to help you understand what current treatments can and can’t do, how they fit into the bigger picture of brain and metabolic health, and how a pharmacist-led, whole-person approach can support thoughtful, informed decisions.

Current Alzheimer’s treatments focus primarily on:
They do not fully reverse the disease, and they work differently for each person. This is why treatment decisions benefit from careful consideration of medical history, medications, lifestyle factors, and personal goals.

Cognitive decline rarely occurs in isolation.
Brain health is closely connected to:
Understanding how these factors interact can make treatment decisions clearer and more personalized.

Donepezil (Aricept®), Galantamine (Razadyne®), Ivastigmine (Exelon®)
🔘 Explore the evidence behind these medications, including how they work, who may benefit, common side effects, and questions to ask your provider.

Lecanemab (Leqembi®), Donanemab (Kisunla™)
These therapies:
Important considerations before starting:
🔘 Look at what the data actually shows, including potential benefits and risks for these drugs.

Medications are most effective when integrated with foundational lifestyle strategies:
Nutrition: Mediterranean-style, anti-inflammatory eating patterns
Movement: Regular aerobic and strength-based activity
Sleep optimization: Intentional sleep optimization
Cognitive engagement: Structured mental stimulation and skill-building
Caregiver education: Training and stress reduction
These approaches can:
🔘 Explore evidence-based brain health strategies — from conventional wellness approaches to precision medicine frameworks, including targeted Bredesen Protocol®.

These medications do not slow Alzheimer’s disease progression, but may help manage agitation or sleep disruption when symptoms affect safety or quality of life.
Brexpiprazole (Rexulti®) is FDA-approved to treat agitation associated with dementia due to Alzheimer’s disease, including restlessness, irritability, or aggressive behaviors.
It works by modulating dopamine and serotonin activity in the brain. This medication is typically considered when non-drug strategies are not enough and requires careful monitoring due to known safety risks in older adults.

Suvorexant (Belsomra®) is used to treat difficulty falling or staying asleep, a common challenge in Alzheimer’s disease.
Unlike traditional sedatives, it works by blocking orexin, a wake-promoting brain chemical. Studies including people with Alzheimer’s show improved total sleep time, which may support daytime function and caregiver well-being.
Medications for agitation or sleep are supportive tools, not first-line Alzheimer’s treatments. They are most appropriate when symptoms interfere with safety, daily care, or caregiver strain.

Alzheimer’s treatment costs vary widely depending on therapy type, disease stage, and insurance coverage.
Traditional medications are often low-cost generics and may be covered by insurance.
Newer biologic therapies can involve high annual costs, along with required imaging and infusion services.
Coverage varies by diagnosis, stage, and payer.

For those seeking deeper, personalized guidance, optional self-pay services may include:
The goal is clearer decisions — not more complexity.

To bring clarity to complex decisions, I use a structured framework called the Functional Medicine (FM) Operating System.
Rather than focusing on isolated symptoms, this holistic approach weaves together treatments, metabolism, lifestyle, and your story into a personalized plan.
The FM Tree is a visual model that helps explain how symptoms such as memory changes, fatigue, or weight gain may stem from shared underlying contributors. It encourages us to look beyond symptoms alone and consider factors like blood sugar balance, inflammation, sleep, stress, medications, and nutrition—all of which influence brain function and metabolism. For caregivers, this approach shifts the focus from “what’s failing” to “what’s influencing,” supporting more compassionate, informed care decisions.
The FM Timeline is a structured way to map your health history across your life to uncover patterns that may still be affecting you today. Because cognitive and metabolic changes often develop gradually, it helps identify when contributors like prolonged stress, medication use, or hormonal shifts began—allowing for more accurate support. For caregivers, this fuller picture reduces confusion, validates lived experience, and builds confidence in next steps.
Curious if this approach is right for you?
The FM Matrix is a clear snapshot of how key body systems—brain, metabolism, digestion, hormones, and immune function—are working together right now. It helps caregivers see how daily habits and supports affect symptoms, making care decisions feel more understandable and less overwhelming. By highlighting which actions have the greatest impact, the Matrix allows caregivers to focus on what matters most, track progress across systems, and support more sustainable changes that promote cognitive resilience and metabolic stability over time.

In early stages, some medications may lead to subtle improvements in attention, focus, or daily functioning within weeks to a few months. Other treatments aim primarily to slow progression, which may not feel immediately noticeable.
Lifestyle strategies — such as improving nutrition, sleep, physical activity, and stress management — may support energy, mood, or daily routines within weeks, while brain-related benefits tend to build over several months. The greatest benefit is often seen when medication care and lifestyle changes are combined early.
In later stages, treatments are less likely to improve memory but may help support behavior, comfort, and daily function. Benefits may include reduced agitation, improved routines, or better tolerance of daily care.
Lifestyle and environmental strategies can still be meaningful, particularly for:
In later stages, success is often measured by quality of life rather than cognitive improvement.
No. Response varies widely based on:
This variability is why treatment plans benefit from ongoing review and individualization rather than a one-size-fits-all approach.
Yes. Alzheimer’s care is dynamic. Medications, doses, and lifestyle strategies may be adjusted as symptoms, goals, or side effects change.
Regular reassessment helps ensure that treatment continues to offer benefit without unnecessary burden — especially as care priorities evolve over time.
Yes. Evidence supports combining medication management with evidence-based lifestyle and supportive strategies at all stages of Alzheimer’s.
While lifestyle changes are not a cure, they may help:
Medication and lifestyle strategies are complementary, not competing — and together often provide the most practical benefit.

If you’d like personalized guidance for your unique situation, schedule a one-on-one consultation.
Together, we can:
The goal is simple: not more care — but better conversations, prioritization, and follow-through.